BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30862134)

  • 21. The prognosis of liver resection for patients with four or more colorectal liver metastases has not improved in the era of modern chemotherapy.
    Hokuto D; Nomi T; Yamato I; Yasuda S; Obara S; Yoshikawa T; Kawaguchi C; Yamada T; Kanehiro H; Nakajima Y
    J Surg Oncol; 2016 Dec; 114(8):959-965. PubMed ID: 27683191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conversion chemotherapy followed by hepatic resection in colorectal cancer with initially unresectable liver-limited metastases.
    Galizia G; De Vita F; Lieto E; Zamboli A; Morgillo F; Castellano P; Mabilia A; Auricchio A; Renda A; Ciardiello F; Orditura M
    Oncol Rep; 2013 Dec; 30(6):2992-8. PubMed ID: 24126855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiofrequency Ablation to Improve Survival After Conversion Chemotherapy for Colorectal Liver Metastases.
    Nielsen K; Scheffer HJ; Volders JH; van der Vorst MJ; van Tilborg AA; Comans EF; de Lange-de Klerk ES; Sietses C; Meijer S; Meijerink MR; van den Tol MP
    World J Surg; 2016 Aug; 40(8):1951-8. PubMed ID: 27220509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first.
    Lim C; Doussot A; Osseis M; Esposito F; Salloum C; Calderaro J; Tournigand C; Azoulay D
    Clin Transl Oncol; 2018 Oct; 20(10):1274-1279. PubMed ID: 29594943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidisciplinary treatment of colorectal liver metastases.
    Schiergens TS; von Einem J; Thomas MN; Albertsmeier M; Giessen-Jung C; Dörsch M; Heiliger C; Drefs M; Andrassy J; Modest DP; Stintzing S; Guba M; Angele M; Werner J; Rentsch M
    Minerva Med; 2017 Dec; 108(6):527-546. PubMed ID: 28889727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
    Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
    BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repeat hepatic resection in patients with colorectal liver metastases.
    Lee H; Choi SH; Cho YB; Yun SH; Kim HC; Lee WY; Heo JS; Choi DW; Jung KU; Chun HK
    World J Gastroenterol; 2015 Feb; 21(7):2124-30. PubMed ID: 25717247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synchronous colorectal liver metastases: the "surgeon as oncologist" perspective.
    Shah K; Clary B
    Minerva Chir; 2013 Feb; 68(1):49-76. PubMed ID: 23584266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of conversion chemotherapy for initially unresectable synchronous colorectal liver metastasis.
    Baba K; Oshita A; Kohyama M; Inoue S; Kuroo Y; Yamaguchi T; Nakamura H; Sugiyama Y; Tazaki T; Sasaki M; Imamura Y; Daimaru Y; Ohdan H; Nakamitsu A
    World J Gastroenterol; 2015 Feb; 21(6):1982-8. PubMed ID: 25684967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases.
    Ercolani G; Cucchetti A; Cescon M; Peri E; Brandi G; Del Gaudio M; Ravaioli M; Zanello M; Pinna AD
    Eur J Cancer; 2011 Oct; 47(15):2291-8. PubMed ID: 21652204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of perioperative chemotherapy in patients with colorectal cancer undergoing hepatectomy for resectable synchronous liver metastasis.
    Nakanishi M; Kuriu Y; Murayama Y; Konishi H; Komatsu S; Shiozaki A; Ikoma H; Kubota T; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Otsuji E
    Hepatogastroenterology; 2014 Sep; 61(134):1582-7. PubMed ID: 25436346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical management of hepatic metastases of colorectal cancer.
    Smith JJ; D'Angelica MI
    Hematol Oncol Clin North Am; 2015 Feb; 29(1):61-84. PubMed ID: 25475573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival and Prognostic Factors of Colorectal Liver Metastases After Surgical and Nonsurgical Treatment.
    Lemke J; Cammerer G; Ganser J; Scheele J; Xu P; Sander S; Henne-Bruns D; Kornmann M
    Clin Colorectal Cancer; 2016 Dec; 15(4):e183-e192. PubMed ID: 27269232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nomogram for prediction of prognosis in patients with initially unresectable colorectal liver metastases.
    Imai K; Allard MA; Castro Benitez C; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Bismuth H; Baba H; Adam R
    Br J Surg; 2016 Apr; 103(5):590-9. PubMed ID: 26780341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic review of outcomes of patients undergoing resection for colorectal liver metastases in the setting of extra hepatic disease.
    Hwang M; Jayakrishnan TT; Green DE; George B; Thomas JP; Groeschl RT; Erickson B; Pappas SG; Gamblin TC; Turaga KK
    Eur J Cancer; 2014 Jul; 50(10):1747-1757. PubMed ID: 24767470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multidisciplinary approach to the diagnosis and treatment of patients with potentially resectable colorectal cancer liver metastasis: results of a multicenter study.
    Han L; Xue J; Wu X; Liang G; Wu Y; Guo F; Gao S; Sun G
    Ann Palliat Med; 2022 Feb; 11(2):717-729. PubMed ID: 35249349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison between perioperative and postoperative chemotherapy after potentially curative hepatic resection for metastatic colorectal cancer.
    Araujo R; Gonen M; Allen P; Blumgart L; DeMatteo R; Fong Y; Kemeny N; Jarnagin W; D'Angelica M
    Ann Surg Oncol; 2013 Dec; 20(13):4312-21. PubMed ID: 23897009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome after laparoscopic radiofrequency ablation of technically resectable colorectal liver metastases.
    Hammill CW; Billingsley KG; Cassera MA; Wolf RF; Ujiki MB; Hansen PD
    Ann Surg Oncol; 2011 Jul; 18(7):1947-54. PubMed ID: 21399885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 'Close shave' in liver resection for colorectal liver metastases.
    Lordan JT; Karanjia ND
    Eur J Surg Oncol; 2010 Jan; 36(1):47-51. PubMed ID: 19502001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.